Scilex Holding CO Form 4 insider transactions

Scilex Holding Co. reports a significant stock transfer by SCLX Stock Acquisition JV LLC to Quantum Scan Holdings, Inc.

Scilex Holding Co. has distributed a stock dividend of Semnur Pharmaceuticals, Inc. common stock to its shareholders and holders of warrants and convertible notes.

Scilex Holding Co. reports a Form 4 filing detailing a warrant transaction by Director and Officer Stephen Ma.

Scilex Holding Co. reports insider transactions involving the acquisition and disposition of warrants by Executive Chairman, CEO, and President Henry Ji.

Scilex Holding Co., a 10% owner and director of Datavault AI Inc., reported the sale of over 15.9 million shares of common stock through a pre-arranged trading plan.

Scilex Holding Co, a 10% owner and director of Datavault AI Inc., reported significant sales of common stock totaling over 14.7 million shares across three days in January 2026.

Scilex Holding Co. filed an amended Form 4 to correct the issuer name to Datavault AI Inc. and reported the sale of over 20 million shares of Datavault AI common stock for approximately $12.8 million in late December 2025.

Scilex Holding Co., a 10% owner and director, reported the sale of over 20 million shares of common stock in late December.

Scilex Holding Co., a 10% owner and director of Datavault AI Inc., exercised warrants for 263.9 million shares and subsequently sold 422,299 shares of common stock.

Scilex Holding Co. Director Wu Yue Alexander was granted 20,000 nonstatutory stock options with an exercise price of $17.58, vesting monthly over 48 months.

Scilex Holding Co's CFO and COO, Stephen Ma, was granted 60,000 incentive stock options with an exercise price of $17.58, subject to vesting and debt repayment conditions.

Scilex Holding Co. Director Jay Chun was granted 20,000 nonstatutory stock options with an exercise price of $17.58, vesting monthly over four years.

Scilex Holding Co. CEO and President Henry Ji was granted 120,000 incentive stock options with an exercise price of $17.58, subject to vesting and debt repayment conditions.

Scilex Holding Co. director Dorman Followwill was granted 20,000 nonstatutory stock options with an exercise price of $17.58.

Scilex Holding Co and Scilex, Inc. sold 12.5 million Semnur shares for $200 million, paid in Bitcoin.

SCLX Stock Acquisition JV LLC transferred 3.25 million shares of Scilex Holding Co common stock to Oramed Pharmaceuticals as part of an amendment to a senior secured promissory note.

SCLX Stock Acquisition JV LLC, a 10% owner of Scilex Holding Co., transferred 779,371 shares of common stock to Rxomeg Therapeutics as part of a licensing agreement amendment.

SCLX Stock Acquisition JV LLC, a 10% owner of Scilex Holding Co, transferred 5 million shares of common stock to noteholders to defer certain amortization payments.

Scilex Holding Co.'s CEO, Jaisim Shah, purchased 30,000 shares of common stock in the open market at an average price of $0.46 per share.

Director Jay Chun acquired 100,000 nonstatutory stock options in Scilex Holding Co on December 16, 2024.

Director Followwill Dorman of Scilex Holding Co acquired 100,000 nonstatutory stock options at an exercise price of $0.5045 on December 16, 2024.

Director Wu Yue Alexander acquired 100,000 nonstatutory stock options in Scilex Holding Co.

Semnur Pharmaceuticals, a subsidiary of Scilex Holding Company, announced the filing of a registration statement on Form S-4 by Denali Capital Acquisition Corp. related to their previously announced business combination.

Executive Chairperson Ji Henry of Scilex Holding Co. reports purchasing additional shares of common stock on October 31, 2024.

Director and Officer Jaisim Shah of Scilex Holding Co. purchased 32,000 shares of SCLX stock on the open market at an average price of $0.9897 on October 29, 2024.

Director Followwill Dorman of Scilex Holding Co. reports purchasing 1,000 shares of common stock at $0.99 per share in an open market transaction.

Director Jay Chun of Scilex Holding Co. [SCLX] purchased 5,000 shares of common stock in an open market transaction on October 18, 2024.

Wu Yue Alexander, a director of Scilex Holding Co, recently purchased 20,000 shares of the company's common stock in an open market transaction.

Director David Lemus purchased 2,000 shares of Scilex Holding Co common stock in an open market transaction on October 17, 2024.

Executive Chairperson Ji Henry of Scilex Holding Co. reports purchasing 10,000 shares of common stock at $0.971 per share.